Filing Flows › Marimed (MRMD) › Q1 2026
Marimed (MRMD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
Marimed (MRMD) reported revenue of $39.5M for the first quarter 2026 (Q1 2026), +4% from a year earlier and -5% from the quarter before. Operating margin was 0.3%, net loss $3.8M (9.5% of revenue).
Marimed, Q1 2026: revenue $39.5M (+4% year over year), operating margin 0.3%, net loss $3.8M, operating cash flow $949K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39.5M | -5% | +4% |
| Operating profit | $125K | — | — |
| Net earnings | −$3.8M | — | — |
| Operating cash flow | $949K | -72% | -27% |
| Free cash flow | $576K | -83% | -44% |
What changed
Revenue was $39.5M in Q1 2026, up 4% year over year and down 5% from the previous quarter. Product sales - retail was the largest line at 55% of revenue. Product sales - retail added $1.0M year over year (up 5%), 63% of the total change. Other revenue declined 39%.
Gross margin was 38.7%, down 1.1 points from Q1 2025. Operating profit was $125K, a 0.3% margin (up 2.7 points year over year). Operating expenses fell 5% while revenue rose 4%. The fastest-growing cost line was General & admin (+10%). The quarter ended with a net loss of $3.8M, narrower than the previous quarter's $4.6M loss.
Operating cash flow was $949K (down 27% year over year). Non-cash charges added back $2.2M of depreciation and amortization and $325K of share-based compensation. Working capital and other items added $2.2M. Capital expenditures of $373K left free cash flow of $576K.
Questions
What was Marimed's revenue in the first quarter 2026?
Marimed (MRMD) reported revenue of $39.5M for the first quarter 2026 (Q1 2026), +4% from a year earlier and -5% from the quarter before.
Was Marimed profitable in the first quarter 2026?
Operating profit was $125K (0.3% of revenue) and net loss $3.8M.
Source: Marimed 10-Q on SEC EDGAR.